Key statistics
Short selling activityProvided by S&P Global Market Intelligence
| Open | 17.65 |
|---|---|
| High | 17.65 |
| Low | 17.65 |
| Bid | 17.31 |
| Offer | 17.42 |
| Previous close | 17.65 |
| Average volume | -- |
|---|---|
| Shares outstanding | 129.81m |
| Free float | 128.02m |
| P/E (TTM) | -- |
| Market cap | 1.28bn USD |
| EPS (TTM) | -0.844 USD |
Data delayed at least 15 minutes, as of Dec 27 2023.
More ▼
Press releases
- NeoGenomics Launches RaDaR ST, Expanding Molecular Residual Disease Testing Across Multiple Solid Tumor Types
- NeoGenomics to Participate in Upcoming Investor Conferences
- NeoGenomics Reports Fourth Quarter and Full Year 2025 Results
- NeoGenomics Introduces PanTracer Pro to Support Timely, Informed Solid Tumor Therapy Selection
- NeoGenomics to Report Fourth Quarter and Full Year 2025 Financial Results on February 17, 2026
- NeoGenomics Announces Preliminary Fourth Quarter and Full-Year 2025 Revenue
- NeoGenomics to Participate in the 44th Annual J.P. Morgan Healthcare Conference
- NeoGenomics Appoints Diagnostics and Lab Services Industry Veteran John P. “Jack” Kenny to its Board of Directors
- NeoGenomics Announces that Natera Has Voluntarily Withdrawn its Appeal in Ongoing RaDaR Patent Litigation
- NeoGenomics to Present New ctDNA Research at SABCS 2025
More ▼
